scispace - formally typeset
M

Martin Lenicek

Researcher at Charles University in Prague

Publications -  61
Citations -  1204

Martin Lenicek is an academic researcher from Charles University in Prague. The author has contributed to research in topics: Bile acid & Population. The author has an hindex of 18, co-authored 55 publications receiving 1022 citations. Previous affiliations of Martin Lenicek include First Faculty of Medicine, Charles University in Prague & Maastricht University.

Papers
More filters
Journal ArticleDOI

The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance

TL;DR: The hepatic response to FGF19 is impaired in NAFLD patients with insulin resistance (HOMA score > or =2.5), which may contribute to the dysregulation of lipid homeostasis inNAFLD.
Journal ArticleDOI

Differences in antitumor effects of various statins on human pancreatic cancer.

TL;DR: Substantial tumor‐suppressive effects of various statins on the progression of experimental pancreatic adenocarcinoma were demonstrated, with marked differences among individual statins, which support greatly the potential of statins for the chemoadjuvant treatment of pancreatic cancer.
Journal ArticleDOI

Bile acid malabsorption in inflammatory bowel disease: assessment by serum markers.

TL;DR: The most severe BAM occurs in CD patients after resection of the distal ileum, but BAM can occur in surgically untreated CD patients, regardless of disease localization.
Journal ArticleDOI

Highly sensitive method for quantitative determination of bilirubin in biological fluids and tissues.

TL;DR: This procedure yielded UCB levels directly comparable to published methods, and accurately determined very low tissue bilirubin concentrations (
Journal ArticleDOI

Determination of beta-defensin genomic copy number in different populations: a comparison of three methods.

TL;DR: QPCR is very sensitive to quality of the template DNA, generating systematic biases that could produce false-positive or negative disease associations, but both triplex PRT and PPRT do not show this systematic bias, and type copy number within the correct range, although triplexPRT appears to be a more precise and accurate method to type beta-defensin copy number.